| Popis: |
Supplementary Table S1: Histopathological features of clinical samples, Supplementary Table S2: Specifications on antibodies used for immune-stainings, Supplementary Figure S1: Example of microdissection of tumor regions, Supplementary Table S3: Mapping statistics of RNA sequencing, Supplementary Table S4: List of differentially expressed genes in N-cadherin positive versus negative EMT regions, Supplementary Table S5: Summary of Ingenuity Pathway Analysis, Supplementary Table S6: List of differentially expressed EMT-associated genes as identified by Ingenuity in N-cadherin negative versus positive regions |
